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Background: Connexin37 (Cx37) and Cx40 are crucial for endothelial cell-cell communication and homeostasis.
Both connexins interact with endothelial nitric oxide synthase (eNOS). The exact contribution of these interactions
to the regulation of vascular tone is unknown.
Results: Cx37 and Cx40 were expressed in close proximity to eNOS at cell-cell interfaces of mouse aortic endothelial
cells. Absence of Cx37 did not affect expression of Cx40 and a 50 % reduction of Cx40 in Cx40+/− aortas did not affect
the expression of Cx37. However, absence of Cx40 was associated with reduced expression of Cx37. Basal NO release
and the sensitivity for ACh were decreased in Cx37−/− and Cx40−/− aortas but not in Cx40+/− aortas. Moreover,
ACh-induced release of constricting cyclooxygenase products was present in WT, Cx40−/− and Cx40+/− aortas but not
in Cx37−/− aortas. Finally, agonist-induced NO-dependent relaxations and the sensitivity for exogenous NO were not
affected by genotype.
Conclusions: Cx37 is more markedly involved in basal NO release, release of cyclooxygenase products and the
regulation of the sensitivity for ACh as compared to Cx40.
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Connexins form a family of transmembrane proteins
[1, 2]. They are inserted into cell membranes as hex-
amers called connexons. Gap junction channels, struc-
tures that arise after docking of two connexons from
neighbouring cells, allow diffusion of ions and small
metabolites (e.g. ATP, Ca2+ and cAMP) between cells
and are thus implicated in direct cell-to-cell communi-
cation and synchronization of tissue responses [3].
Under specific conditions, connexons may also func-
tion as hemichannels allowing for diffusion of ions and
small metabolites from the cytosol to the extracellular
space or vice versa [4].* Correspondence: merlijn.meens@unige.ch
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creativecommons.org/publicdomain/zero/1.0/It is now increasingly recognized that connexins do
not only function as connexons or gap junction chan-
nels; they can also regulate the function of other pro-
teins via protein-protein interactions [5–7]. It has for
instance been demonstrated that Cx37 interacts with
eNOS [8]. Moreover, these interactions between Cx37
and eNOS reduce basal nitric oxide (NO) release in vitro
[8]. However, a specific role for Cx37-eNOS interactions
at the organ level remains to be addressed. In addition,
it has been shown that Cx40 interacts with eNOS and
that Cx40-deficient mice are characterized by reduced
endothelium-dependent NO-mediated relaxations [9].
However, Cx37 is also reduced in Cx40-deficient mice
[9]. It is thus unclear whether Cx37-eNOS interactions,
Cx40-eNOS interactions or both are responsible for the
vascular phenotype of Cx40-deficient mice. Therefore,
the current study addressed whether Cx37-deficiency,
Cx40-deficiency or a 50 % reduced expression of
Cx40 affects basal or agonist-induced release of NO.
The key findings are that mainly Cx37 directly modulates
i) the spontaneous release of NO from mouse aorticticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lial cells for ACh and iii) the agonist-induced release of
endothelium-derived COX-generated contractile factors.
Results and discussion
Mouse aortic endothelial cells express Cx37 and Cx40 but
not Cx43s
The cellular localization of Cx37, Cx40 and Cx43 was
studied by immunofluorescence performed on en face
preparations of WT, Cx37−/− and Cx40−/− aortas. These
experiments showed that WT mouse aortic endothelial
cells expressed Cx37 and Cx40 at cell-cell interfaces
whereas Cx43 was barely detectable (Fig. 1a-c). In
Cx37−/− endothelium, Cx37 and Cx43 were not de-
tected and the immunosignal for Cx40 was comparable
to the Cx40 immunosignal in WT endothelium
(Fig. 1d-f ). Finally, in Cx40−/− endothelium, Cx40 and
Cx43 were not found and the immunosignal for Cx37
was reduced as compared to the Cx37 immunosignal
in WT endothelium (Fig. 1g-i). In summary, i) Cx37
and Cx40 are expressed at intercellular junctions of
mouse aortic endothelial cells, ii) the level of Cx37 ex-
pression seems to be dependent on the expression of
Cx40 and iii) Cx43 is barely detectable in mouse aorticFig. 1 Mouse aortic endothelial cells express Cx37 and Cx40 at cell-cell interfac
stainings for Cx37 (a), Cx40 (b) or Cx43 (c) in wild-type (WT) mouse aortic endot
immunofluorescent stainings for Cx37 (d), Cx40 (e) or Cx43 (f) in Cx37−/− mous
focal immunofluorescent stainings for Cx37 (g), Cx40 (h) or Cx43 (i) in Cx40−/− mendothelium. Expression of Cx43 in rat aortic endothe-
lium is mainly restricted to areas exposed to disturbed
blood flow [10], hence a low level of Cx43 expression
in mouse aortic endothelial cells of the thoracic aorta
was in line with expectations. Moreover, this study was
performed on a part of the thoracic aorta that is exposed to
high laminar shear stress, a condition that likely increases
expression of Cx37 expression due to its effect on the tran-
scription factor KLF2 [11] and that might increase expres-
sion of Cx40 due to the activation of Akt similar to the
situation in arterioles [12]. Interestingly, the immunosignal
for Cx37 seemed reduced in Cx40−/− mouse aortic endo-
thelial cells whereas the immunosignal for Cx40 was not al-
tered in Cx37−/− endothelium. Thus, there might be
interdependence of Cx37 and Cx40 expression.
Cx40-deficiency affects endothelial Cx37 expression
To further study whether expression of Cx37 affects the
expression of Cx40 or vice versa, the expression of Gja4
(the gene coding for mouse Cx37) or Gja5 (the gene
coding for mouse Cx40) was quantified by real-time
PCR performed on total aortic mRNA. As expected,
mRNA coding for Cx37 was detectable in WT aortas but
not in Cx37−/− aortas (Fig. 2a). Moreover, mRNA codinges. a-c Representative images of en face confocal immunofluorescent
helium, respectively. d-f Representative images of en face confocal
e aortic endothelium, respectively. g-i Representative images of en face con-
ouse aortic endothelium, respectively. Scalebar equals 15 μM
Fig. 2 Cx37-deficiency does not affect expression of Cx40 while Cx40-deficiency reduces expression of Cx37. a-b Total mRNA was isolated from
aortas obtained from WT, Cx37−/−, Cx40−/− or Cx40+/− mice (N = 3). Thereafter, the expression of Gja4 (A, the gene coding for Cx37) or Gja5 (B,
the gene coding for Cx40) was assessed by real-time PCR. Cx40 is expressed at WT levels in the Cx37−/− aortas while Cx37 showed large variation
and tended to be reduced in the Cx40−/− aortas (p = 0.08). Moreover, expression of Cx37 is not reduced in Cx40+/− aortas. c Representative image
of Cx37 and Cx40 protein expression in scraped mouse aortic endothelial cells as assessed by western blot. Tubulin and von Willebrand factor
(vWf) were assessed for equal protein loading. d Cx37 protein quantification (N = 6–8). Similar to the expression of Cx37 at the level of RNA, Cx37
expression was reduced by half in Cx40−/− aortic endothelial cells whereas Cx37 expression was not significantly reduced in Cx40+/− endothelium.
e Cx40 protein quantification (N = 6–8). Cx40 was diminished by half in Cx40+/− endothelial cells and was not altered in Cx37−/− endothelium.
Values are expressed as mean ± SEM. *, ** or *** p < 0.05, 0.01 or 0.001 vs WT control, respectively
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duced in Cx40−/− aortas (p = 0.08) and was comparable
to WT levels in Cx40+/− aortas (Fig. 2a). These findings
are in line with an earlier study showing that endothelial
Cx40-deficient mice do not display significantly reduced
Cx37 mRNA levels in both the aorta and the cremaster
muscle [13]. mRNA coding for Cx40 was expressed at
similar levels in WT and Cx37−/− aortas (Fig. 2b). mRNA
expression does not necessarily predict protein expres-
sion due to for example posttranslational modifications,
alternative splicing, etc. [14]. Expression of Cx37 and
Cx40 protein content was therefore also assessed bywestern blotting performed on mouse aortic endothe-
lial cells collected from WT, Cx37−/− or Cx40−/− mice
(see Fig. 2c for a representative example from 6 to 8
mice). These experiments confirmed that Cx37 was
reduced in Cx40−/− aortic endothelial cells as com-
pared to WT endothelium (Fig. 2d, e). Thus, in line
with earlier findings in mouse arterioles [15] and the mouse
aorta [9, 16], Cx37 was reduced in Cx40−/− endothelial cells.
Moreover, in line with yet another study [17], Cx40 expres-
sion was not affected by absence of Cx37. Subsequently,
the expression of Cx37 and Cx40 was studied in Cx40+/−
mouse aortic endothelial cells. As expected, these studies
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by about 50 % in Cx40+/− endothelial cells at the level of
mRNA (Fig. 2b; p = 0.09) and was significantly reduced at
the level of protein (Fig. 2c and e; p < 0.01). However, the
expression of Cx37 in Cx40+/− aortic endothelial cells
was not significantly different from its expression in
WT aortic endothelium (Fig. 2a, c and d). In conclu-
sion, expression of Cx40 seems to be necessary for
proper expression of Cx37 in mouse aortic endothe-
lium. However, even low levels of Cx40 expression, like
in Cx40+/− mice, are sufficient to maintain Cx37 ex-
pression at a level comparable to WT aortic endothe-
lium. As recently demonstrated [13], maintenance of
endothelial Cx37 may depend on the presence of Cx40
rather than to its channel function. Altogether, by
using Cx40+/− aortas the effect of a specific reduction
in Cx40 expression on vasomotor function can be
studied independent from a reduction in Cx37.Fig. 3 Interactions between connexins and eNOS are present at cell-cell in
of proximity ligation assays performed with antibodies targeting Cx37 and
mouse aortic endothelium. b Cx40 staining to highlight the intercellular ga
eNOS and Cx37 at the gap junctions between endothelial cells. d Close pro
light the intercellular gap junctions. f Merge of (d) and (e) highlighting clo
lial cells. g-i Control assays revealed that the intense red staining observed
the proximity ligation assays (g-i) even though cell-cell junctions could clea
lar results, were performed with the Cx40 antibodies, but not the Cx37 ant
equals 20 μMCx37 and Cx40 are in close proximity to eNOS in mouse
aortic endothelium
Similar to Cx37 and Cx40, eNOS can also be found at
cell-cell interfaces in aortic endothelium. Moreover,
Cx37 and Cx40 have been suggested to interact with
eNOS in cellular junctions of endothelial cells [8, 9].
Here, the possible interactions between Cx37, Cx40 and
eNOS were studied using in situ proximity ligation as-
says. Cx37 and eNOS (Fig. 3a-c), and Cx40 and eNOS
(Fig. 3d-f ) were detected in close proximity at cell-cell
interfaces in mouse aortic endothelium. Importantly, no
signal was detected in negative controls from which the
antibody detecting eNOS was omitted (Fig. 3g-i and j-l).
Moreover, interactions between Cx37 and Cx40 were de-
tected at intercellular junctions of WT aortic endothelial
cells (Additional file 1: Figure S1 A-B) and these were
absent between Cx40−/− endothelial cells (Additional
file 1: Figure S1 C-D), further illustrating the specificityterfaces between mouse aortic endothelial cells. Representative images
eNOS or Cx40 and eNOS. a Close proximity of Cx37 and eNOS in WT
p junctions. c Merge of (a) and (b) highlighting close proximity of
ximity of Cx40 and eNOS in WT endothelium. e Cx37 staining to high-
se proximity of eNOS and Cx40 at the gap junctions between endothe-
in a-c was no longer observed after omitting the eNOS antibody from
rly be visualized (h-i). j-l: Similar control stainings, which revealed simi-
ibodies present during the proximity ligation assays. Scalebar
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both Cx37 and Cx40 are in close proximity with eNOS
at intercellular junctions of mouse aortic endothelial
cells. Hence, both Cx37 and Cx40 might regulate eNOS-
mediated aspects of vasomotor function.
Cx37 is involved in basal NO-mediated vasomotor
responses
The data in this study show that Cx37 and Cx40 are i)
expressed at cell-cell interfaces and ii) in a close proxim-
ity to eNOS. Thus, they suggest that endothelial Cx37 ex-
pression may be dependent on proper Cx40 expression.
Moreover, these findings imply that Cx37 and/or Cx40
could regulate eNOS-dependent NO production in vivo
and warrant studies towards a possible role of interactions
between Cx37 or Cx40 and eNOS in basal NO release at
the organ level. Consequently, we assessed phenylephrine
(PHE)-induced contractions in aortas isolated from WT,
Cx37−/−, Cx40−/− and Cx40+/− mice using wire-myography.
Initially, PHE-induced in absence of pharmacological inhib-
itors were studied. These experiments showed that the
amplitude of the PHE-induced contractions was signifi-
cantly enhanced in Cx37−/− and Cx40−/− aortas as com-
pared to WT aortas (Fig. 4, Table 1). The amplitude of
these contractions, which result from activation of adrener-
gic receptors expressed by vascular smooth muscle cells,
depends on i) the balance between the relative amount of
vasoconstrictors and vasodilators present in the organ bath
and ii) the amount of vascular smooth muscle cells in the
vessel wall. Indeed, as expected, given the hypertension-
induced hypertrophy of the vascular smooth muscle in the
Cx40−/− aortas [9], the PHE-induced contractions were sig-
nificantly enhanced in the Cx40−/− aortas as compared to
the Cx37−/− and WT aortas (Fig. 4, Table 1). Interestingly,
in case of basal NO release, one would expect that
presence of the NOS inhibitor Nω-nitro-l-arginine me-
thyl ester (L-NAME) would increase the contractile
amplitude. Indeed, the amplitude of PHE-induced con-
tractions was significantly increased in aortas isolated
from WT mice in presence of L-NAME (Fig. 4a,
Table 1). This was not the case in aortas isolated from
Cx37−/− (Fig. 4b, Table 1) or Cx40−/− mice (Fig. 4c,
Table 1). Presence of L-NAME significantly increases
PHE-induced contractions in aortas isolated from
Cx40+/− mice that are characterized by a 50 % reduced
expression of Cx40 but normal Cx37 expression levels
(Fig. 4d, Table 1). In conclusion, our observations in
Cx37−/−, Cx40+/− and Cx40−/− aortas show that Cx37 is
implicated in basal NO release. Although it cannot be
completely ruled out that the remaining level of Cx40
expression in Cx40+/− aortas is sufficient for the gener-
ation of basal NO levels comparable to WT aortas, the
apparent involvement of Cx40 is most likely explained
by an indirect mechanism (e.g. via the regulation ofCx37 expression). However, Cx37 seems to be neces-
sary for a direct regulation of eNOS function since
basal NO release in Cx37−/− aortas, which have normal
Cx40 expression levels, was reduced. Exactly how Cx37
regulates the basal release of NO is currently unclear.
One possibility would be via direct effects on eNOS ex-
pression levels. We therefore studied eNOS expression
by western blotting of mouse aortic endothelial cell ly-
sates collected from WT, Cx37−/−, Cx40−/− or Cx40+/−
mice. In line with previous findings [9, 18], eNOS ex-
pression was reduced in Cx40−/− endothelium, but ex-
pression levels were similar in Cx37−/−, Cx40+/− and
WT mice (Fig. 5e). NO production in the endothelium
results from a complex series of interactions between
eNOS, Ca2+, calmodulin, caveolin and tetrahydropiop-
terin [19]. Theoretically, Cx37 could alter e.g. binding
of any of these factors to eNOS thereby changing its
activity and increasing NO release. Indeed, the C-
terminal tail of Cx37 interacts with eNOS at its reduc-
tase domain, a part that also contains a caveolin-1
binding site [8]. Finally, one should keep in mind that
“mixed channels” composed of both Cx37 and Cx40
may be involved in regulation of NO release as well.
Involvement of Cx37 or Cx40 in agonist-induced NO
release
Basal and activated NO release do not necessarily de-
pend on similar mechanisms. Findings regarding basal
NO release can therefore not always be extrapolated to
activated NO release. For that reason, CRCs to acetyl-
choline (ACh) during PHE-induced pre-contractions in
aortas isolated from WT, Cx37−/−, Cx40−/− or Cx40+/−
mice were studied. In WT aortas ACh induced relaxa-
tions that reached maximal amplitudes at an ACh con-
centration of 300 nM (Fig. 5a, Table 2). However, in
presence of indomethacin (INDO) the CRCs for ACh
only reached maximal amplitude at an ACh-
concentration of 10 μM (Fig. 5a, Table 2). Finally, ACh-
induced relaxations were dramatically reduced in pres-
ence of L-NAME (maximal relaxation −11 ± 2 %) and in
presence of L-NAME + INDO (Fig. 5a; maximal relax-
ation 4 ± 2 %). Thus, in WT aortas ACh-induced relaxa-
tions are fully mediated by NO and can be partially
masked by INDO-sensitive contractile factors at high
ACh concentrations. Surprisingly, the CRCs for ACh
that were generated in Cx37−/− aortas were character-
ized by a lower sensitivity compared to CRCs generated
in WT aortas (Table 3) and were unaffected by INDO
(Fig. 5b, Table 2). Similar to its effect in WT-aortas,
presence of L-NAME drastically reduced the effect of
ACh in Cx37−/− aortas (Fig. 5b). CRCs for ACh gener-
ated in aortas from Cx40-deficient animals were also
characterized by a lower sensitivity compared to CRCs
generated in WT aortas (Table 3). However, INDO
Table 1 Characteristics of PHE-induced contractions in presence or absence of L-NAME
Emax (mean (mN) ± SEM) EC50 (mean (nM) 95 % CI)
WT Cx37−/− Cx40−/− Cx40+/− WT Cx37−/− Cx40−/− Cx40+/−
Control 3.1 ± 0.2 4.0 ± 0.5 $$$, §§§ 6.0 ± 0.5 $$$ 1.9 ± 0.4 §§§ 91 95 % CI [57, 145] 48 95 % CI [25, 94] 39 95 % CI [20, 78] 84 95 % CI [24, 291]
L-NAME 4.1 ± 0.3*** 3.7 ± 0.6 4.9 ± 0.9 3.7 ± 0.7*** 39 95 % CI [24, 62] 24 95 % CI [5, 115] 26 95 % CI [12, 57] 37 95 % CI [8, 160]
N = 6–10. ***, $$$, §§§ p < 0.001 vs the respective control, WT or Cx40−/−










































































































Fig. 4 Cx37 is implicated in basal NO release. Aortic segments obtained from WT, Cx37−/−, Cx40−/− or Cx40+/− mice were mounted in a wire-myograph
and concentration-response curves for PHE were generated in presence or absence of L-NAME (100 μM). a Inhibition of NO synthesis by L-NAME increased
the contractile amplitude for PHE in WT aortas indicating presence of basal NO release. This effect of L-NAME was not observed in aortas isolated from
Cx37−/− (b) or Cx40−/− (c) mice. In contrast (d), in aortas obtained from Cx40+/− mice L-NAME did increase the contractile amplitude of PHE. Values are
expressed as mean ± SEM. N= 6–10. **, *** p< 0.01, 0.001 vs control, respectively. e Representative image and quantification of eNOS protein expression in
protein samples from scraped mouse aortic endothelial cells as assessed by western blot. Values are expressed as mean ± SEM. N= 6–8. * p< 0.05 vs WT
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Fig. 5 Cx37 may be implicated in the release of COX products but not in activated NO release. Concentration-response curves for the
endothelium-specific agonist ACh were generated in PHE pre-contracted aortas obtained from WT, Cx37−/−, Cx40−/− or Cx40+/− mice. a WT aortas
displayed relaxations in response to ACh (black) which were i) increased in presence of INDO (blue) and ii) inhibited in presence of L-NAME (red)
or in presence of L-NAME and INDO (green). b Cx37−/− aortas displayed relaxation responses to ACh (black) which were i) unaffected by presence
of INDO (blue), ii) inhibited in presence of L-NAME (red) or in presence of L-NAME and INDO (green). c Aortas obtained from Cx40−/− mice (c)
displayed relaxations in response to ACh (black) which were i) slightly, but significantly, increased in presence of INDO (blue) and ii) inhibited in
presence of L-NAME (red) or in presence of L-NAME and INDO (green). d Aortas obtained from Cx40+/− mice displayed relaxations in response to
ACh (black) which were i) increased in presence of INDO (blue) and ii) inhibited in presence of L-NAME (red) or in presence of L-NAME and INDO
(green). Values are expressed as mean ± SEM. N = 6–10. *, ** or *** p < 0.05, 0.01 or 0.001 vs. control, respectively
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effect of ACh in Cx40−/− aortas (Fig. 5c, Table 2). In line
with expectations, L-NAME also reduced the effects of
ACh in the Cx40−/− aortas (Fig. 5c, Table 2). Finally,
CRCs for ACh generated in Cx40+/− aortas were similar in
all aspects to those generated in WTaortas (Fig. 5d, Table 2
and Table 3). In summary, Cx37 and Cx40 do probably not
affect the activated NO release. Cx37, however, seems im-
plicated in the release of constricting COX products in re-
sponse to higher ACh concentrations since a significant
effect on INDO was not observed in Cx37−/− aortas (which
express Cx40 at WT levels) but was observed in Cx40−/−
aortas (which express low levels of Cx37) and in Cx40+/−Table 2 Emax of ACh-induced relaxations during PHE-induced
contractions in presence or absence of INDO, L-NAME or a com-
bination of the former
Emax (mean (% relaxation) ± SEM)
WT Cx37−/− Cx40−/− Cx40+/−
Control 51 ± 9 50 ± 7 47 ± 7 50 ± 9
INDO 83 ± 5*** 63 ± 12 71 ± 8* 98 ± 3**
L-NAME −11 ± 2*** −8 ± 6*** 6 ± 4*** −8 ± 4***
L-NAME + INDO 4 ± 2*** 6 ± 5*** 2 ± 3*** 3 ± 16**
N = 6–10. *, ** or *** p < 0.05, 0.01 or 0.001 vs controlaortas (which express Cx37 at WT levels). Furthermore,
changes in the expression of Cx37 are most likely also re-
sponsible for the changes in the sensitivity for ACh that
were observed since these changes were fully normalized in
Cx40+/− aortas. However, half of Cx40 expression may also
be sufficient for normal endothelial function. Surprisingly,
ACh-induced NO-mediated dilatation was not affected by
Cx40 (or by Cx37; this study) in contrast to earlier work
from our group [9]. The reasons for this discrepancy are
not entirely clear but are most likely due to methodological
differences between the studies (e.g. the use of different ag-
onists to induce precontractions, cumulative vs non-
cumulative CRCs, different timing of agonist application).
Involvement of Cx37 or Cx40 in release of contractile
factors
Various studies have described endothelium-dependent
contractile effects of high ACh concentrations [20–23].
Indeed, in the current study the lower ACh concentra-
tions induced relaxations that no longer increased at
higher ACh concentrations in WT aortas. It has been
shown that COX1-derived products mediate contractile
effects of ACh in the mouse aorta [20]. We therefore
assessed the effect of blocking cyclooxygenases using
INDO (a dual COX1/COX2 inhibitor) on ACh-induced
Table 3 EC50 (mean (nM) 95 % CI) for ACh during PHE-induced contraction in presence of INDO
WT Cx37−/− Cx40−/− Cx40+/−
23 95 % CI [15, 35] 409 95 % CI [153, 1088]* 274 95 % CI [125, 604]* 19 95 % CI [11, 32]
* p < 0.05 vs WT
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creased the maximal effect of ACh in WT, Cx40−/− and
Cx40+/− but not Cx37−/− aortas. Interestingly, it has been
suggested that gap junctional communication between
endothelial cells or, alternatively, between endothelium
and smooth muscle cells could be responsible for the
contractile effects of ACh in the aorta of spontaneously-
hypertensive rats [21]. However, this latter study relied
on rather non-specific chemical inhibitors such as carbe-
noxolone and only addressed the role of connexins in
the context of hypertension, a disease that is well-known
to alter the distribution of connexins in the vascular wall
[24]. As effects of INDO on the Emax of ACh-induced
relaxations was observed in WT, Cx40+/− and Cx40−/−
aortas but not in Cx37−/− aortas, we conclude that Cx37
is necessary to allow the effect of INDO.
Connexin deficiency does not alter the sensitivity for NO
The altered sensitivity for ACh that was observed in
Cx37−/− and Cx40−/− aortas may be due to i) a changed
sensitivity of the aortic endothelial cells for ACh, ii) an
altered eNOS expression level (in the Cx40−/− but not
the Cx37−/− aortas) or iii) a changed sensitivity of
the vascular smooth muscle cells for NO. The latter pos-
sibility was tested by generating CRCs to an NO donor
(sodium-nitroprusside, (SNP)) during PHE-induced pre-
contractions (in presence of L-NAME and INDO to
avoid effects of endogenous NO or COX-products, re-
spectively) in WT, Cx37−/−, Cx40−/− or Cx40+/− aortas.
These experiments showed that aortas isolated from
WT, Cx37−/−, Cx40−/− or Cx40+/− mice were equally
sensitive to NO (Table 4). In summary, the changed sen-
sitivity for ACh, which was observed in Cx37−/− and
Cx40−/− aortas, was not due to alterations at the smooth
muscle level (e.g. a decreased sensitivity of the ‘NO re-
ceptor’ soluble guanylyl cyclase (sGC)) but likely
reflected endothelial changes. Indeed, involvement of
Cx40 (and most likely Cx37) in the endothelial Ca2+
agonist responses, which govern NO release, are agonist
specific [25]. I.e. ATP-induced increases in intracellular
Ca2+ in mouse endothelium are homogeneous and do
not require synchronization by connexins [25]. In con-
trast, Ca2+ elevations mediated by ACh are heterogenousTable 4 EC50 (mean (nM) 95 % CI) for SNP during PHE-induced
contraction in presence of L-NAME and INDO
WT Cx37−/− Cx40−/− Cx40+/−
7 95 % CI [4, 14] 5 95 % CI [2, 10] 3 95 % CI [1, 30] 4 95 % CI [1, 20]and require synchronization by connexins to reach other
cells [25]. This observation sparks thoughts such as
‘thus, the diminished response to ACh makes sense since
ACh-induced responses require synchronization via con-
nexins’. However, although this is theory true for the
total amount of NO released by aortic endothelial cells
exposed to a certain ACh concentration (an effect that
was not actually observed in this study), this theory does
not hold regarding sensitivity changes. Such changes
most likely involve conformational changes of the M3-
receptor or enzymes, like eNOS, functioning down-
stream of M3-receptor activation but upstream of the
activation of sGC. eNOS seems a likely candidate since
Cx37 and Cx40 have not been shown to interact with
M3 receptors (nor do they co-localize with M3 receptors
in mouse aortic endothelial cells (see Fig. 4 in [25]))
but do interact with this NO-generating enzyme.
Tantalizingly, if the basal intracellular Ca2+ concentra-
tion is unaffected by genotype then a decreased eNOS
sensitivity for Ca2+ could explain both the effect ob-
served regarding basal NO release (decreased NO re-
leased at fixed Ca2+ concentration) and the apparent
effect on sensitivity of ACh (increasing concentrations of
ACh result in increasing concentrations of intracellular
Ca2+ that do not have similar effects due to the altered
Ca2+ sensitivity of eNOS). Obviously, this will be the
topic of further studies.
Conclusions
In summary, the current study was conducted to address
whether Cx37 or Cx40 is more pronouncedly involved
in the regulation of vasomotor function. The data indi-
cate that Cx37 is more markedly involved in basal NO
release, release of COX-products and the regulation of
the sensitivity for ACh as compared to Cx40. These find-
ings are exciting since they, for the first time, allow for a
discrimination of the functional role of Cx37 and Cx40
in mouse aortic endothelium. However, various ques-
tions remain e.g. ‘How does Cx37 modulate basal NO
release without modulating eNOS expression levels?’,
and importantly, ‘Why is the sensitivity for ACh altered
in Cx37−/− aortas’. Clearly, these questions warrant a
specific exploration in further studies.
Methods
The Swiss Federal Veterinary Office approved animal
housing and animal experiments. Wild-type (WT, n = 10),
Cx37−/− (n = 10), Cx40−/− (n = 8) and Cx40+/− (n = 8) mice
were progeny of the original colony on a C57BL/6 J
Table 5 Contraction (mN) upon exposure to K+ (40 mM) before
exposure to pharmacological inhibitors
WT Cx37−/− Cx40−/− Cx40+/−
1.8 ± 0.2 2.8 ± 0.3* 3.9 ± 0.3*** 1.8 ± 0.2
N = 6–10. * or *** p < 0.05 or 0.001 vs WT
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cycle [26, 27]. Genotyping was performed as previously
described [17, 9].
Immunofluorescence and in situ proximity ligation assays
Immunostainings and in situ proximity ligation assays
were performed as previously described [9, 11]. In brief,
for immunostainings, opened thoracic aortas were fixed
in ice-cold methanol, permeabilized with 0.2 % TritonX-
100 and blocked in 2 % bovine serum albumin. Primary
antibodies (polyclonal rabbit anti-Cx37 (alpha Diag-
nostic), anti-Cx40 (Chemicon), anti-Cx43 (alpha Diag-
nostic) were incubated overnight. An Alexa Fluor 488
fluorochrome-conjugated goat-anti rabbit was used for
signal detection. Nucleic acids were stained with DAPI
and the cytosol was visualized using Evans Blue. Finally,
sections were mounted and analysed using a LSM 510
Meta confocal microscope (Zeiss). For the proximity
ligation assays, longitudinally opened aortas were fixed
in 100 % ethanol, and aortic strips prepared for the sim-
ultaneous incubation with rabbit polyclonal antibody
against Cx40 (Chemicon) or Cx37 (Biotrend Chemika-
lien) and mouse monoclonal antibody against eNOS
(BD Bioscience). The incubation solution was then sup-
plemented with oligonucleotide-conjugated secondary
antibodies (diluted 1:5) and a ligation solution, consist-
ing of two nucleotides and a ligase, to form a circular
DNA when eNOS and Cx40 or Cx37 were in close
proximity. The circular DNA was then amplified into a
long, single-stranded concatemer by rolling circle amp-
lification, using as primer an arm of one of the
oligonucleotide-conjugated antibodies. The amplification
product was collapsed into a DNA bundle, and detected
by hybridizing fluorophore-labeled oligonucleotides
(Duolink in situ detection reagent red) to the repeated
sequences of the amplification product. Under a fluor-
escence microscope, the result was detected as red
spots, which were localized by staining the EC nuclei
with DAPI. For the proximity ligation assays performed
with antibodies targeting Cx40 and Cx37 in the en face
aortic strips, a monoclonal antibody specific to mouse
Cx40 was used (Invitrogen).
Quantitative PCR
RNA isolation, DNAse treatment and reverse tran-
scriptase reactions were performed on whole mouse
aortas as previously described [11]. Equal loading wasensured by assessing expression of 18S ribosomal RNA
and was similar in all samples. The relative amount of
mRNA of interest was calculated after normalization to
CD31 for the amount of endothelium in the samples.
Western blotting
The expression of Cx37 and Cx40 was determined
as previously described [9]. In brief, thoracic aortas
were longitudinally opened in 100 μl PBS, and were
subsequently pinned on a silicone plate with the
endothelial-side facing upwards. A scalpel blade was
then used to gently scrape off the ECs. ECs in PBS were
then centrifuged at 14,000 rpm for 5 min at 4 °C and the
pellet was homogenized in lysis buffer (62.5 mM Tris HCl,
pH6.8, 5 % SDS, 10 mM EDTA, pH8). Protein content was
measured using a detergent-compatible DC protein assay
kit (Bio-Rad Laboratories). Samples (20 μg) were equally
loaded on a 10 % polyacrylamide gel, separated by electro-
phoresis and transferred onto PVDF membranes (Immo-
bilon-P; Millipore). Membranes were incubated for 1 h in
PBS or TBS containing 5 % milk and 0.1 % Tween 20
(blocking buffer). The membranes were then incubated
overnight at 4 °C with one of the following primary anti-
bodies: rabbit polyclonal antibodies against Cx40 (Chemi-
con), Cx37 (Biotrend Chemikalien) or von Willebrand
factor (vWF) (Dako) and mouse monoclonal antibodies
against α-tubulin (Sigma-Aldrich) or eNOS (BD Bio-
science). The secondary antibodies were horseradish
peroxidase-conjugated goat anti-mouse immunoglobulin
(Jackson Immuno research); or goat anti-rabbit immuno-
globulin (Thermo Scientific), respectively. Bands were de-
veloped using enhanced chemiluminescence (Millipore),
and visualized using a supercooled CCD camera (Chemidoc
XRS). Densitometric analysis was performed using Image-
Lab Software (3.0.1 Bio-Rad Laboratories). Equal loading
was ensured by assessing expression of tubulin and was
similar in all the samples. The relative amount of the pro-
teins of interest was calculated after normalization to vWf
for the amount of endothelium in the samples.
Solutions and drugs
Krebs-Ringer bicarbonate-buffered physiological salt
buffer (KRB-buffer) contained 118.5 mM NaCl, 4.7 mM
KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4,
25.0 mM NaHCO3 and 5.5 mM glucose. High K
+-KRB
solution was prepared by replacing NaCl with KCl.
Buffers containing intermediate K+ concentrations were
prepared by mixing volumes of KRB and K+-KRB.
Acetylcholine (ACh), phenylephrine (PHE), Nω-nitro-l-
arginine methyl ester (L-NAME), sodium-nitroprusside
(SNP) and indomethacin (INDO) were obtained from
Sigma-Aldrich (Germany). All compounds were dis-
solved in KRB-buffer with the exception of INDO, which
was dissolved in ethanol.
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Mice were sedated (ketamine (100 mg/kg) + xylazine
(100 mg/kg), i.p. injection). Subsequently, the left
ventricle was punctured with a 23 G needle. Then, the
animals were perfused during 3 min under constant
flow (flow rate 3.33 mL/min) with a total volume of
10 mL KRB-buffer (pre-heated at 37 °C). After perfu-
sion, aortic segments were isolated and mounted in a
multi-myograph (610 M; DMT, Aarhus, Denmark).
After mounting, the segments were stretched to the
diameter at which maximal contractile responses to
40 mM K+ (Kmax) were obtained (Table 5). Next, to test
endothelial integrity, arteries were washed precon-
tracted using PHE (10 μM) and subsequently exposed
to ACh (10 μM). Within each genotype, all segments
displayed relaxing responses of equal magnitude in re-
sponse to this muscarinic receptor agonist (data not
shown). Thereafter, a concentration-response curve
(CRC) for PHE (1 nM – 10 μM) was generated. Subse-
quently, during the stabilized contractile response to
10 μM PHE, a CRC for ACh (1 nM – 10 μM) was con-
structed. Twenty minutes after the CRC for ACh the ar-
terial segments were again precontracted using PHE
(10 μM). Then, in order to test the NO sensitivity of the
vascular smooth muscle cells in the preparation, a CRC
for SNP (0.1 nM – 10 μM) was generated during the
stabilized contractile response to PHE. These experi-
ments were conducted in parallel in presence of L-
NAME (100 μM; to block the synthesis of NO), INDO
(10 μM; to block the synthesis of prostaglandins) or a
combination of the former.
Statistical analyses
Results are shown as mean ± SEM. One or two-way
ANOVAs followed by Bonferroni’s multiple comparisons
tests were performed using Graphpad Prism 6.0 to com-
pare mean values between the groups. P-values < 0.05
were considered statistically significant.Additional file
Additional file 1: Interactions between Cx37 and Cx40 at cell-cell
interfaces between mouse aortic endothelial cells.
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